Ameriprise
LBRX

Ameriprise’s LB Pharmaceuticals LBRX Stock Holding History

Ameriprise’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38M Buy
227,485
+119,178
+110% +$3.5M ﹤0.01% 2274
2026
Q1 		$2.67M Sell
108,307
-85,237
-44% -$1.97M ﹤0.01% 2816
2025
Q4 		$4.31M Buy
193,544
+116,094
+150% +$2.03M ﹤0.01% 2541
2025
Q3 		$1.22M Buy
+77,450
New +$1.23M ﹤0.01% 3254

Other funds holding LBRX

DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Ameriprise's LBRX Position: Q2 2026 in Review

Ameriprise increased its LB Pharmaceuticals (LBRX) stake by 110% in Q2 2026, buying an estimated $3.5M and bringing the position to 227,485 shares worth $7.38M. The position accounts for ﹤0.01% of the portfolio, ranked #2274.

Ameriprise first reported a position in LBRX in Q3 2025 and has held it in 4 quarters since. 115 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Ameriprise held 227,485 shares of LB Pharmaceuticals worth $7.38M as of Q2 2026.
  • Ameriprise bought 119,178 LB Pharmaceuticals shares in Q2 2026, an estimated $3.5M.
  • LB Pharmaceuticals made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2274 holding.
  • Ameriprise first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 115 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.